TY - JOUR A2 - Grant-Kels, Jane M. AU - Bagheri, Mansooreh AU - Eghtedari, Masoomeh AU - Bagheri, Mandana AU - Geramizadeh, Bita AU - Talebnejad, Mohammadreza PY - 2014 DA - 2014/12/15 TI - Expression of Maspin and Ezrin Proteins in Periocular Basal Cell Carcinoma SP - 596564 VL - 2014 AB - Background.The aim of this study was to investigate maspin and ezrin expression in different subtypes of periocular basal cell carcinoma (BCC). Methods.Tissue samples from 43 patients with periocular BCC. Our cases were comprised of 10 morpheaform, 25 nodular, and 8 adenoid type BCCs. Immunohistochemical staining for maspin and ezrin was performed by Envision detection system. Results.There was no difference between different subtypes of BCC in maspin expression regarding positivity, intensity, and pattern of expression. Ezrin was expressed in all subtypes of BCC but the intensity was significantly higher in morpheaform BCC compared to nodular and adenoid types ( P < 0.001 and P = 0.012 , resp.); ninety percent of morpheaform samples showed strong ezrin intensity, while this strong intensity was only present in 25% and 12% of adenoid and nodular subtypes, respectively. There was no correlation between age, sex, or tumor margin involvement and expression of neither maspin nor ezrin. There was no correlation between maspin and ezrin expression except in nodular type, in which an inverse correlation was found ( P = 0.004 ) . Conclusion.Ezrin is expressed intensely in morpheaform BCC of periocular region. Further studies are needed to show the significance of this finding in prognosis of morpheaform BCC. SN - 1687-6105 UR - https://doi.org/10.1155/2014/596564 DO - 10.1155/2014/596564 JF - Dermatology Research and Practice PB - Hindawi Publishing Corporation KW - ER -